Rubric Capital Management 13F holdings, Q4 2023
Holdings as of December 31, 2023 · filings on SEC EDGAR · latest filing →
Rubric Capital Management disclosed 57 US equity positions worth $2.7bn in its Q4 2023 13F filing. The largest position was ROIV at 8.0% of the reported book, followed by TEVA and VTRS. Against the Q3 2023 filing, it opened 7 new positions, added to 19 and reduced 13 among the top 50 holdings.
What did Rubric Capital Management own in Q4 2023? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2023 |
|---|---|---|---|---|---|---|---|
| 1 | ROIV ROIVANT SCIENCES LTD | Healthcare | 8.0% | $213.4m | 19,000,000 | 81% | added |
| 2 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.1% | $190.3m | 18,226,601 | -4% | reduced |
| 3 | VTRS VIATRIS INC | Healthcare | 7.1% | $190.3m | 17,567,892 | 33% | added |
| 4 | GLNG GOLAR LNG LTD | Energy | 5.6% | $149.6m | 6,506,757 | 0% | held |
| 5 | BGC BGC GROUP INC | Financial Services | 5.4% | $144.4m | 20,000,000 | 0% | held |
| 6 | 07WA MR COOPER GROUP INC | 4.3% | $116.3m | 1,785,795 | -9% | reduced | |
| 7 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 3.2% | $84.9m | 2,758,253 | -13% | reduced |
| 8 | RENEW ENERGY GLOBAL PLC | 3.0% | $79.8m | 10,420,000 | 5% | added | |
| 9 | QDEL QUIDELORTHO CORP | Healthcare | 2.7% | $72.2m | 980,063 | 231% | added |
| 10 | PACTIV EVERGREEN INC | 2.6% | $69.1m | 5,039,766 | 1% | added | |
| 11 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.3% | $62.0m | 1,125,000 | 33% | added |
| 12 | VYX NCR VOYIX CORPORATION | Technology | 2.3% | $60.7m | 3,591,228 | – | new |
| 13 | SSYS STRATASYS LTD | Technology | 2.3% | $60.7m | 4,250,000 | 367% | added |
| 14 | FLR FLUOR CORP NEW | Industrials | 2.2% | $59.2m | 1,510,172 | -37% | reduced |
| 15 | CSTM CONSTELLIUM SE | Basic Materials | 2.2% | $58.4m | 2,924,438 | 50% | added |
| 16 | ADEA ADEIA INC | Technology | 2.1% | $57.5m | 4,640,009 | 0% | held |
| 17 | AIR AAR CORP | Industrials | 2.1% | $55.9m | 895,904 | -27% | reduced |
| 18 | DOLE DOLE PLC | Consumer Defensive | 2.1% | $55.7m | 4,530,940 | 21% | added |
| 19 | LIBERTY GLOBAL LTD | 2.0% | $52.9m | 2,979,328 | – | new | |
| 20 | KOP KOPPERS HOLDINGS INC | Basic Materials | 1.9% | $51.6m | 1,007,341 | -12% | reduced |
| 21 | KINIKSA PHARMACEUTICALS LTD | 1.9% | $51.0m | 2,907,501 | -6% | reduced | |
| 22 | OFIX ORTHOFIX MED INC | Healthcare | 1.8% | $49.4m | 3,665,000 | 7% | added |
| 23 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 1.8% | $48.6m | 8,000,000 | 99% | added |
| 24 | HRTX HERON THERAPEUTICS INC | Healthcare | 1.7% | $45.4m | 26,713,503 | 0% | held |
| 25 | PARR PAR PAC HOLDINGS INC | Energy | 1.6% | $43.6m | 1,199,749 | -39% | reduced |
| 26 | TAC TRANSALTA CORP | Utilities | 1.6% | $42.8m | 5,145,630 | 17% | added |
| 27 | MATV MATIV HOLDINGS INC | Basic Materials | 1.5% | $41.1m | 2,682,400 | -33% | reduced |
| 28 | GDRX GOODRX HLDGS INC | Healthcare | 1.5% | $39.3m | 5,872,806 | – | new |
| 29 | PLAYA HOTELS & RESORTS NV | 1.4% | $38.3m | 4,431,161 | -15% | reduced | |
| 30 | ZYME ZYMEWORKS INC | Healthcare | 1.3% | $36.1m | 3,475,384 | 31% | added |
| 31 | LIBERTY GLOBAL LTD | 1.3% | $34.5m | 1,852,856 | – | new | |
| 32 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 1.2% | $31.3m | 13,552,997 | 17% | added |
| 33 | XPER XPERI INC | Technology | 1.1% | $28.2m | 2,555,632 | -37% | reduced |
| 34 | ARDX ARDELYX INC | Healthcare | 0.9% | $24.9m | 4,012,753 | 61% | added |
| 35 | SCPHARMACEUTICALS INC | 0.8% | $21.9m | 3,500,000 | 29% | added | |
| 36 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 0.8% | $21.5m | 6,644,530 | 32% | added |
| 37 | RSKD RISKIFIED LTD | Technology | 0.7% | $19.5m | 4,173,636 | 159% | added |
| 38 | OMNIAB INC | 0.7% | $17.6m | 2,850,588 | 0% | held | |
| 39 | SILK RD MED INC | 0.7% | $17.5m | 1,427,905 | – | new | |
| 40 | OVID OVID THERAPEUTICS INC | Healthcare | 0.6% | $17.1m | 5,315,969 | -2% | reduced |
| 41 | PCRX PACIRA BIOSCIENCES INC | Healthcare | 0.6% | $16.6m | 491,322 | 7% | added |
| 42 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.5% | $14.3m | 3,344,810 | 0% | held |
| 43 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 0.5% | $14.0m | 2,862,729 | – | new |
| 44 | REVANCE THERAPEUTICS INC | 0.5% | $12.8m | 1,461,474 | -9% | reduced | |
| 45 | FIP FTAI INFRASTRUCTURE INC | 0.5% | $12.4m | 3,193,530 | 0% | held | |
| 46 | TSAT TELESAT CORP | 0.4% | $10.0m | 959,764 | 0% | held | |
| 47 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.3% | $7.6m | 5,684,420 | 0% | held |
| 48 | HOWL WEREWOLF THERAPEUTICS INC | 0.3% | $7.5m | 1,935,357 | 0% | held | |
| 49 | CNNE CANNAE HLDGS INC | Consumer Cyclical | 0.3% | $7.1m | 362,961 | – | new |
| 50 | CGEM CULLINAN ONCOLOGY INC | Healthcare | 0.2% | $6.4m | 626,929 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.